Choong Financial Statements From 2010 to 2024

072020 Stock  KRW 10,010  20.00  0.20%   
Choong Ang financial statements provide useful quarterly and yearly information to potential Choong Ang Vaccine investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Choong Ang financial statements helps investors assess Choong Ang's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Choong Ang's valuation are summarized below:
Choong Ang Vaccine does not presently have any fundamental signals for analysis.
Check Choong Ang financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Choong Ang's main balance sheet or income statement drivers, such as , as well as many indicators such as . Choong financial statements analysis is a perfect complement when working with Choong Ang Valuation or Volatility modules.
  
This module can also supplement various Choong Ang Technical models . Check out the analysis of Choong Ang Correlation against competitors.

Choong Ang Vaccine Company Current Valuation Analysis

Choong Ang's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Choong Ang Current Valuation

    
  163.05 B  
Most of Choong Ang's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Choong Ang Vaccine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Choong Ang Vaccine has a Current Valuation of 163.05 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.

Choong Ang Vaccine Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Choong Ang's current stock value. Our valuation model uses many indicators to compare Choong Ang value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Choong Ang competition to find correlations between indicators driving Choong Ang's intrinsic value. More Info.
Choong Ang Vaccine is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about  0.01  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Choong Ang Vaccine is roughly  151.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Choong Ang by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Choong Ang's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Choong Ang Financial Statements

Choong Ang stakeholders use historical fundamental indicators, such as Choong Ang's revenue or net income, to determine how well the company is positioned to perform in the future. Although Choong Ang investors may analyze each financial statement separately, they are all interrelated. For example, changes in Choong Ang's assets and liabilities are reflected in the revenues and expenses on Choong Ang's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Choong Ang Vaccine. Please read more on our technical analysis and fundamental analysis pages.
Choong Ang Vaccine Laboratory Co., Ltd. engages in the production and sale of animal biological products primarily in Korea. The company, formerly known as ChoongAng Veterinary Infectious Diseases Research Institute, was founded in 1968 and is based in Daejeon, South Korea. CAVAC is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Choong Ang

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Choong Ang position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Choong Ang will appreciate offsetting losses from the drop in the long position's value.

Moving together with Choong Stock

  0.71102940 Kolon Life SciencePairCorr
  0.88074430 Aminologics CoLtdPairCorr
The ability to find closely correlated positions to Choong Ang could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Choong Ang when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Choong Ang - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Choong Ang Vaccine to buy it.
The correlation of Choong Ang is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Choong Ang moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Choong Ang Vaccine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Choong Ang can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Choong Stock

Choong Ang financial ratios help investors to determine whether Choong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Choong with respect to the benefits of owning Choong Ang security.